![logo](/logos/300501.SZ.webp)
Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd.
SZSE:300501.SZ
14.24 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,010.39 | 1,012.601 | 856.858 | 713.785 | 621.03 | 507.196 | 375.617 | 301.276 | 293.978 | 289.85 | 277.367 | 210.237 | 149.003 |
Cost of Revenue
| 726.016 | 740.934 | 609.812 | 469.975 | 427.524 | 341.493 | 235.136 | 184.72 | 185.931 | 188.197 | 182.267 | 139.113 | 99.055 |
Gross Profit
| 284.374 | 271.667 | 247.046 | 243.81 | 193.507 | 165.703 | 140.481 | 116.556 | 108.048 | 101.653 | 95.1 | 71.125 | 49.949 |
Gross Profit Ratio
| 0.281 | 0.268 | 0.288 | 0.342 | 0.312 | 0.327 | 0.374 | 0.387 | 0.368 | 0.351 | 0.343 | 0.338 | 0.335 |
Reseach & Development Expenses
| 47.573 | 44.491 | 32.878 | 24.294 | 26.437 | 23.264 | 16.865 | 16.362 | 16.778 | 16.157 | 15.703 | 10.136 | 0 |
General & Administrative Expenses
| 14.546 | 14.887 | 12.924 | 16.472 | 27.12 | 13.165 | 12.81 | 5.901 | 5.173 | 2.829 | 3.295 | 2.509 | 16.213 |
Selling & Marketing Expenses
| 54.731 | 45.608 | 42.561 | 50.962 | 38.645 | 31.78 | 21.903 | 14.432 | 13.045 | 13.528 | 12.86 | 10.208 | 8.281 |
SG&A
| 117.17 | 60.495 | 55.485 | 67.434 | 65.765 | 44.944 | 34.713 | 20.333 | 18.217 | 16.356 | 16.156 | 12.717 | 24.494 |
Other Expenses
| -8.349 | 0.24 | -0.352 | -0.7 | -0.802 | 0.123 | 0.915 | 0.928 | 2.125 | 2.707 | 0.89 | 0.179 | 0.053 |
Operating Expenses
| 173.092 | 149.095 | 136.034 | 127.938 | 126.609 | 92.05 | 66.369 | 47.848 | 44.05 | 40.553 | 38.681 | 29.075 | 24.62 |
Operating Income
| 111.281 | 122.683 | 117.785 | 119.445 | 73.929 | 76.877 | 75.957 | 72.986 | 66.367 | 61.191 | 53.006 | 41.034 | 23.292 |
Operating Income Ratio
| 0.11 | 0.121 | 0.137 | 0.167 | 0.119 | 0.152 | 0.202 | 0.242 | 0.226 | 0.211 | 0.191 | 0.195 | 0.156 |
Total Other Income Expenses Net
| -9.489 | 0.24 | -0.352 | -0.7 | -0.802 | 0.123 | 0.915 | 0.876 | 2.123 | 2.707 | 0.887 | 0.161 | 0.026 |
Income Before Tax
| 101.792 | 122.923 | 117.434 | 118.744 | 73.127 | 77 | 76.872 | 73.862 | 68.49 | 63.898 | 53.892 | 41.195 | 23.319 |
Income Before Tax Ratio
| 0.101 | 0.121 | 0.137 | 0.166 | 0.118 | 0.152 | 0.205 | 0.245 | 0.233 | 0.22 | 0.194 | 0.196 | 0.156 |
Income Tax Expense
| 14.642 | 13.071 | 8.404 | 13.317 | 7.393 | 12.636 | 11.172 | 8.894 | 9.706 | 9.607 | 9.412 | 7.136 | 3.528 |
Net Income
| 85.442 | 102.461 | 104.646 | 102.904 | 66.976 | 66.165 | 65.811 | 64.604 | 58.767 | 54.224 | 44.466 | 34.058 | 19.791 |
Net Income Ratio
| 0.085 | 0.101 | 0.122 | 0.144 | 0.108 | 0.13 | 0.175 | 0.214 | 0.2 | 0.187 | 0.16 | 0.162 | 0.133 |
EPS
| 0.44 | 0.53 | 0.64 | 0.67 | 0.44 | 0.44 | 0.43 | 0.56 | 0.52 | 0.48 | 0.39 | 0.3 | 0.18 |
EPS Diluted
| 0.44 | 0.53 | 0.64 | 0.67 | 0.43 | 0.44 | 0.43 | 0.56 | 0.52 | 0.48 | 0.39 | 0.3 | 0.18 |
EBITDA
| 168.508 | 182.461 | 167.124 | 164.267 | 115.925 | 105.438 | 90.615 | 83.003 | 76.054 | 68.618 | 63.009 | 48.153 | 26.704 |
EBITDA Ratio
| 0.167 | 0.18 | 0.195 | 0.23 | 0.187 | 0.208 | 0.241 | 0.276 | 0.259 | 0.237 | 0.227 | 0.229 | 0.179 |